Prevalence of HPV infection and anal and cervical cytological abnormalities in transgender people at a referral service in Vitória, Espírito Santo state, Brazil, between 2018 and 2021
2024

HPV Infection and Cytological Abnormalities in Transgender People in Brazil

Sample size: 110 publication Evidence: moderate

Author Information

Author(s): Franco Luís Salume Costa, Boldrini Neide Aparecida Tosato, Caldeira Caroline Simões, Ferrugini Carolina Loyola Prest, Volpini Lays Paula Bondi, Saldanha Fenísia Gabrielle Carvalho, Soares Lucas Delboni, Miranda Angelica Espinosa

Primary Institution: Universidade Federal do Espírito Santo

Hypothesis

What is the prevalence of HPV and cytological abnormalities in transgender individuals?

Conclusion

HPV is a prevalent infection with risks for cytological abnormalities in the transgender population, and further studies on prevalence and impacts on sexual health are needed to support screening and prevention policies.

Supporting Evidence

  • 58.3% of participants tested positive for HPV.
  • 23.5% of transgender women had abnormal anal cytology.
  • 9.5% of transgender men had abnormal cervical cytology.
  • 12.5% prevalence of trichomoniasis was found.
  • 4.1% prevalence of chlamydia was found.
  • Participants reported high rates of never having undergone screening for cervical/anal neoplasia.

Takeaway

This study found that many transgender people have HPV, which can cause health problems, so it's important to help them get the right check-ups.

Methodology

A descriptive study was conducted in a transgender outpatient clinic, collecting data through interviews and medical records, and testing anogenital samples for HPV and other STIs.

Potential Biases

Participants' refusal to undergo sample collection may introduce bias, as those who declined may differ from those who participated.

Limitations

The study's cross-sectional design limits causal inferences, and the sample size was relatively small, which may have affected some comparisons.

Participant Demographics

60.9% identified as men, 34.5% as women, with ages ranging from 17 to 61 years and a mean age of 27.7 years.

Statistical Information

Confidence Interval

95% CI calculated for prevalence of abnormal cytology.

Digital Object Identifier (DOI)

10.1590/S2237-96222024v33e2024279.especial.en

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication